About Index Trending news
Analyze
Pricing
Caribou Biosciences

Caribou Biosciences

Caribou Biosciences

Pioneering the revolutionary field of CRISPR-Cas genome editing to advance therapeutics, agricultural biotech, biological research, and industrial biotech.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series B)
$30,000,000
Heritage Group, Novartis, F-Prime Capital Partners, +5
Venture capital
Employees

Team size

10+
Locations
HQ
$30,000,000 Venture capital (Series B)
FinSMEs

Caribou Biosciences Completes $30M Series B Funding

Funding Science
Venture capital
GEN

GEN | News Highlights:Novartis Launches CRISPR Collaborations with Intellia, Caribou